{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:19Z","timestamp":1792189159837,"version":"4.4.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea funded by the Korean Government","award":["grant 2019R1F1A1060899"],"award-info":[{"award-number":["grant 2019R1F1A1060899"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p><jats:italic>Pneumocystis jirovecii<\/jats:italic> pneumonia (PCP) is a fatal respiratory infection, mostly associated with immunocompromised conditions. Several reports have described PCP development in patients who were not immunocompromised, but the clinical course and prognosis of PCP are not well understood. We compared the clinical characteristics and prognoses between patients with and without immunocompromised conditions who developed PCP.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We retrospectively analyzed patients who had been treated for PCP from three hospitals. We defined immunocompromised (IC) status as following: human immunodeficiency virus (HIV) infection; hematological malignancy; solid organ tumor under chemotherapy; rheumatic disease; medication with immunosuppressive agents. Patients without immunocompromised status were defined as being non-immunocompromised (non-IC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The IC and non-IC groups comprised 173 and 14 patients. The median ages were 62.0 and 74.0 years in the IC and the non-IC group, respectively. The median interval between admission and anti-PCP treatment was significantly longer for patients in the non-IC group than that for patients in the IC group (7 vs. 2 days). The in-hospital mortality rates were significantly higher for patients in the non-IC group than that for patients in the IC group (71.4% vs. 43.9%; P = 0.047). A longer interval between admission and anti-PCP therapy was associated with increased 90-day mortality rate in patients with PCP (hazard ratio, 1.082; 95% confidence interval, 1.015\u20131.153; P = 0.016).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Patients with PCP with no predisposing illnesses were older and had higher mortality rates than IC patients with PCP. Delayed anti-PCP treatment was associated with increased 90-day mortality.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0246296","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T09:08:42Z","timestamp":1612516122000},"page":"e0246296","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness"],"prefix":"10.1371","volume":"16","author":[{"given":"Tae-Ok","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Chul","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Gun","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4837-1321","authenticated-orcid":true,"given":"In-Jae","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-7687","authenticated-orcid":true,"given":"Young-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-3491","authenticated-orcid":true,"given":"Hong-Joon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"12","key":"pone.0246296.ref001","doi-asserted-by":"crossref","first-page":"1242 e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"P Fillatre","year":"2014","journal-title":"Am J Med"},{"issue":"1","key":"pone.0246296.ref002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia","volume":"96","author":"HJF Salzer","year":"2018","journal-title":"Respiration"},{"issue":"2","key":"pone.0246296.ref003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4046\/trd.2020.0015","article-title":"Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia","volume":"83","author":"S. Tasaka","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"26","key":"pone.0246296.ref004","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJM199212243272606","article-title":"treatment of pneumocystis pneumonia","volume":"327","author":"Masur H. Prevention","year":"1992","journal-title":"N Engl J Med"},{"issue":"21","key":"pone.0246296.ref005","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"W Hughes","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0246296.ref006","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"KA Sepkowitz","year":"1992","journal-title":"JAMA"},{"issue":"6","key":"pone.0246296.ref007","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/313534","article-title":"Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients","volume":"29","author":"R Nuesch","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0246296.ref008","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"NG Mansharamani","year":"2000","journal-title":"Chest"},{"issue":"2","key":"pone.0246296.ref009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years\u2019 experience of infection in GIMEMA centres","volume":"117","author":"L Pagano","year":"2002","journal-title":"Br J Haematol"},{"issue":"11\u201312","key":"pone.0246296.ref010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365540410021180","article-title":"Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia","volume":"36","author":"F Roblot","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"pone.0246296.ref011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-11-76","article-title":"Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes","volume":"11","author":"Y Matsumura","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0246296.ref012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.hlc.2011.10.006","article-title":"Unusual presentation of pneumocystis pneumonia in an immunocompetent patient diagnosed by open lung biopsy","volume":"21","author":"K Harris","year":"2012","journal-title":"Heart Lung Circ"},{"issue":"3","key":"pone.0246296.ref013","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/sur.2011.099","article-title":"Pneumocystis jiroveci pneumonia in an immunocompetent patient","volume":"13","author":"G Maggi","year":"2012","journal-title":"Surg Infect (Larchmt)"},{"key":"pone.0246296.ref014","first-page":"3981681","article-title":"Pneumocystis jirovecii Pneumonia in an Immunocompetent Japanese Man: A Case Report and Literature Review","volume":"2019","author":"H Ide","year":"2019","journal-title":"Case Rep Pulmonol"},{"issue":"2","key":"pone.0246296.ref015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ccm.2009.02.005","article-title":"Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment","volume":"30","author":"BJ Krajicek","year":"2009","journal-title":"Clin Chest Med"},{"issue":"9","key":"pone.0246296.ref016","doi-asserted-by":"crossref","first-page":"e73099","DOI":"10.1371\/journal.pone.0073099","article-title":"Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review.","volume":"8","author":"LC Fan","year":"2013","journal-title":"PLoS One."},{"issue":"6\u20137","key":"pone.0246296.ref017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/00365540601131976","article-title":"Improved detection of Pneumocystis jirovecii infection in a tertiary care reference hospital","volume":"39","author":"R Gupta","year":"2007","journal-title":"India. Scand J Infect Dis"},{"issue":"4","key":"pone.0246296.ref018","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.00095811","article-title":"Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients","volume":"39","author":"K Muhlethaler","year":"2012","journal-title":"Eur Respir J"},{"issue":"10","key":"pone.0246296.ref019","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.01554-13","article-title":"Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-beta-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization","volume":"51","author":"C Damiani","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"8","key":"pone.0246296.ref020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome","volume":"34","author":"KA Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0246296.ref021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.medmal.2009.08.006","article-title":"Pneumocystis jiroveci pneumonia in an immunocompetent female patient","volume":"40","author":"H Nejmi","year":"2010","journal-title":"Med Mal Infect"},{"issue":"4","key":"pone.0246296.ref022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199101243240407","article-title":"A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses","volume":"324","author":"JL Jacobs","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0246296.ref023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.104.2.376","article-title":"Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases","volume":"104","author":"S Cano","year":"1993","journal-title":"Chest"},{"issue":"1","key":"pone.0246296.ref024","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"X Monnet","year":"2008","journal-title":"Crit Care"},{"issue":"11","key":"pone.0246296.ref025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jiac.2019.06.007","article-title":"Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole","volume":"25","author":"H Kato","year":"2019","journal-title":"J Infect Chemother"},{"issue":"2","key":"pone.0246296.ref026","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"E Festic","year":"2005","journal-title":"Chest"},{"issue":"12","key":"pone.0246296.ref027","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thx.2009.117846","article-title":"Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study","volume":"64","author":"MW Fei","year":"2009","journal-title":"Thorax"},{"issue":"21","key":"pone.0246296.ref028","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199011223232131","article-title":"Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome","volume":"323","author":"National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis P","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0246296.ref029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/598651","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients","volume":"29","author":"C Delclaux","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pone.0246296.ref030","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1128\/AAC.00669-11","article-title":"Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients","volume":"55","author":"SM Moon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0246296.ref031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"MC Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"issue":"35","key":"pone.0246296.ref032","doi-asserted-by":"crossref","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis","volume":"8","author":"Y Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"pone.0246296.ref033","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JCM.03174-15","article-title":"Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients","volume":"54","author":"T Fauchier","year":"2016","journal-title":"J Clin Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T09:09:09Z","timestamp":1612516149000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246296"}},"subtitle":[],"editor":[{"given":"Walter R.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246296","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]}}}